ESR1 and breast carcinoma: Treatment options for hormone receptor-positive breast cancers include selective estrogen receptor modulators (SERMs), such as tamoxifen (NovadexTM) or Fulvestrant (FaslodexTM), and aromatase inhibitors, which block estrogen production, such as anastrozole (ArimidezTM) and exemestane (AromasinTM).